Variability and Post-op AEs: Does Preoperative CardioPulmonary Variability Assessment Identify Risk of Postoperative Adverse Events Following Thoracic Surgery
Launched by OTTAWA HOSPITAL RESEARCH INSTITUTE · Jun 3, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving the safety of major thoracic surgeries, like those for lung, esophageal, or gastric cancer. Researchers want to see if assessing how well a patient's heart and lungs respond to stress before surgery can help predict the risk of complications after the operation. By understanding this "cardiopulmonary variability," doctors hope to create more personalized care plans to prevent problems and improve recovery for patients undergoing these surgeries.
To participate in this study, you need to be an adult, at least 18 years old, and scheduled for a major thoracic surgery. However, if you have certain heart conditions like atrial fibrillation, are pregnant, or are undergoing emergency surgery, you won’t be eligible. If you join, you can expect to undergo a preoperative assessment that looks at your heart and lung function. This could help your healthcare team better understand your individual risk factors and tailor your care to ensure a safer surgical experience.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patient (≥18 years of age)
- • Patients undergoing major thoracic resection for lung, esophageal or gastric cancer or mediastinal tumour (at least lobectomy, pneumonectomy, esophagectomy, gastrectomy, or mediastinal tumour resection)
- Exclusion Criteria:
- • Urgent/emergent cases
- • Patients with pre-existing atrial fibrillation or arrhythmia (persistent/paroxysmal)
- • Patients that are pacemaker dependent
- • Patients unable to participate in preoperative testing protocol (CardioPulmonary Variability Assessment)
- • Patients that are pregnant
About Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute (OHRI) is a leading academic research institute dedicated to advancing health and healthcare through innovative research and evidence-based practices. Affiliated with The Ottawa Hospital and the University of Ottawa, OHRI fosters a collaborative environment that brings together clinicians, scientists, and trainees to conduct groundbreaking clinical trials and translational research. With a focus on improving patient outcomes, OHRI specializes in a wide range of fields, including cancer, cardiovascular health, and regenerative medicine. The institute is committed to ethical research practices and the dissemination of knowledge to enhance public health and inform healthcare policy.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Andrew JE Seely, MD, PhD, FRSCS
Principal Investigator
The Ottawa Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported